Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , IPO , cancer , drugs , Taiwan

   

Next In Business News

Shares rise ahead of Nvidia results; BOJ keeps rates markets guessing
Shanghai will reduce real estate transaction taxes to boost demand, state media says
China pivotal to MNCs' global biz strategy
CMM, BCG publish report on venture capital funding in Malaysia
MMAG granted waiver from GN3 status
I-Berhad posts earnings jump to RM12.94mil in 3Q
EA Technique unit bags three contract extensions with PETRONAS for RM63.9mil
CelcomDigi records 3Q net profit of RM436.98mil, declares 3.6c div/share
FBM KLCI rebounds over 10 points to cross 1,600 level
Thai Q3 GDP grows 3.0 y-o-y, fastest pace in two years

Others Also Read